A prospective cross sectional observational study on prevalence of clinical manifestations and hormonal abnormalities associated with polycystic ovarian disease

https://doi.org/10.54037/WJPS.2021.91211

Authors

  • I.S.V. Manvita Department of Pharmacy Practice, Malla Reddy College of Pharmacy, Affiliated to Osmania University, Maisammaguda, Dhulapally Secunderabad-500100, Telangana, India
  • G Sravani Department of Pharmacy Practice, Malla Reddy College of Pharmacy, Dhulapally, Secunderabad, Telangana-500100 (Affiliated to Osmania University).
  • M. Sudhakar Department of Pharmacy Practice, Malla Reddy College of Pharmacy, Dhulapally, Secunderabad, Telangana-500100 (Affiliated to Osmania University).
  • Malathi Department of Gynecology, Malla Reddy Hospital, Suraram, Hyderabad, Telangana 500018
  • B. Bhavani Department of Pharmacy Practice, Malla Reddy College of Pharmacy, Dhulapally, Secunderabad, Telangana-500100 (Affiliated to Osmania University).
  • Janvi Varma Department of Pharmacy Practice, Malla Reddy College of Pharmacy, Dhulapally, Secunderabad, Telangana-500100 (Affiliated to Osmania University).
  • Anusha Department of Pharmacy Practice, Malla Reddy College of Pharmacy, Dhulapally, Secunderabad, Telangana-500100 (Affiliated to Osmania University).
  • Ramya Uppala Department of Pharmacy Practice, Malla Reddy College of Pharmacy, Dhulapally, Secunderabad, Telangana-500100 (Affiliated to Osmania University).
  • Azmira Aktar Department of Pharmacy Practice, Malla Reddy College of Pharmacy, Dhulapally, Secunderabad, Telangana-500100 (Affiliated to Osmania University).

Keywords:

Polycystic ovarian disease, Clinical manifestations, Hormonal abnormalities

Abstract

Polycystic ovarian disorder (PCOD) is the most common hormonal disorder seen in females of reproductive worldwide.  From the very limited data, PCOD prevalence in India ranges from 3.7% to 22.5%. Polycystic Ovarian disease requires "control" rather than "cure", the treatment decisions depend on symptoms, age, whether or not the women want to become pregnant. Aim: To study the prevalence of clinical manifestations and hormonal abnormalities associated with PCOD. Methodology: This prospective observational study was carried out in gynaecology department of Mallareddy hospital, where subjects were enrolled based on inclusion and exclusion criteria. All 100 patients demographics were documented. The prevalence of clinical manifestations and hormonal abnormalities in all subjects were assessed. Results: Irregular menstruation was seen as the most common clinical manifestation and seen in maximum 66% of subjects, Hirsutism was seen in 35% of the cases followed by  acne   in 28% of cases , androgenic alopecia  in 22% of cases and  acanthosis nigricans in minority 7% of cases .When the subjects were assessed for hormonal abnormalities, 52% of the subjects showed decreased FSH, 48% of the subjects had increased LH, 9%  had decreased and 33 % had increased PRL,  38% showed increased Testosterone, 21% had decreased and 7% had increased T3, T4 levels. Conclusion:   Irregular menstruation was seen as the most common clinical manifestation followed by dermatologic manifestations – Hirsutism, Acne, Acanthosis nigricans and androgenic alopecia. Clinical manifestations diagnosis can lead to early treatment in these patients and  helps them  in relieving their symptoms and  improve quality of life.

Downloads

Published

2021-12-01

How to Cite

I.S.V. Manvita, G Sravani, M. Sudhakar, Malathi, B. Bhavani, Janvi Varma, Anusha, Ramya Uppala, & Azmira Aktar. (2021). A prospective cross sectional observational study on prevalence of clinical manifestations and hormonal abnormalities associated with polycystic ovarian disease: https://doi.org/10.54037/WJPS.2021.91211. World Journal of Pharmaceutical Sciences, 9(12), 212–217. Retrieved from https://wjpsonline.com/index.php/wjps/article/view/clinical-manifestations-hormonal-abnormalities-pcod

Issue

Section

Research Article

Most read articles by the same author(s)